Diastolic heart failure: A myth

Current Opinion in Cardiology

Volumn 21, Issue 3, 2006, Pages 240-248

  Brutsaert, Dirk L ^a   De Keulenaer, Gilles W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

CHARM Trial; Systolic function; Ventricular hemodynamic pump; Ventricular muscular pump

Indexed keywords

CHRONOLOGY; CLINICAL ASSESSMENT; DIASTOLIC HEART FAILURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART PROTECTION; HEART VENTRICLE FUNCTION; HUMAN; MEDICAL RESEARCH; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTOLE; SYSTOLIC HEART FAILURE; TREATMENT PLANNING;

CARDIAC OUTPUT, LOW; DIASTOLE; HEART FAILURE, CONGESTIVE; HUMANS; PHENOTYPE; STROKE VOLUME; SYSTOLE;

EID: 33748210723     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000221587.02114.da     Document Type: Review

References (94)

1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43:317-327.
2. Thomas MD, Fox KF, Coats AJ, Sutton GC. The epidemiological enigma of heart failure with preserved systolic function. Eur J Heart Fail 2004; 6:125-136.
3. Vasan RS, Larson MG, Benjamin EJ, Evans JC, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33:1948-1955.
4. Chen HH, Lainchbury JG, Senni M, et al. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002; 8:279-287.
5. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005; 47:320-332. Excellent survey of the epidemiology of HFprEF.
6. Yancy CW, Lopatin M, Stevenson LW, et al. ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006; 47:76-84.
7. Masoudi FA, Havranek EP, Smith G, et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41:217-223.
8. Borbely A, van der Velden J, Papp Z, et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111:774-781. Experimental study demonstrating increased passive stiffness of single cardiomyocytes isolated from patients with HFprEF, presumably caused by a reduced phosphorylation of sarcomeric proteins.
9. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350:1953-1959.
10. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107:714-720.
11. Redfield MM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005; 112:2254-2262. [Epub ahead of print] Epidemiological study confirming general cardiovascular stiffening, as demonstrated by Kawaguchi et al. [9] in patients with HFprEF.
12. Munagala VK, Hart CY, Burnett JC Jr, et al. Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure. Circulation 2005; 111:1128-1135. Experimental model of HFprEF - aged dogs with chronic hypertension, exhibiting LV hypertrophy and fibrosis but no increase in LV diastolic stiffness; impaired LV systolic relaxation, as a cause of HFprEF, results from the LV afterload imbalance between increased LV systolic and arterial stiffness.
13. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004; 94:1533-1542.
14. Redfield MM. Treating diastolic heart failure with AGE crosslink breakers: thinking outside the heart failure box. J Card Fail 2005; 11:196-199.
15. Little WC, Brucks S. Therapy for diastolic heart failure. Prog Cardiovasc Dis 2005; 47:380-388. Critical update of currently used therapies in patients with HFprEF.
16. Massie BM, Fabi MR. Clinical trials in diastolic heart failure. Prog Cardiovasc Dis 2005; 47:389-395.
17. Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 2001; 38:1277-1282.
18. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005; 111:2306-2312.
19. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005; 111:2837-2849.
20. Solomon SD, Anavekar N, Skali H, et al. Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005; 112:3738-3744.
21. Brutsaert DL, Sys SU. Relaxation and diastole of the heart. Physiol Rev 1989; 69:1228-1315.
22. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 2003; 83:59-115.
23. Brutsaert DL, Sys SU. Diastolic dysfunction in heart failure. J Card Fail 1997; 3:225-242.
24. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26:195-202.
25. Hay I, Rich J, Ferber P, et al. Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol 2005; 288:H1203-H1208. Computer simulation emphasizing the importance of the timing of onset of relaxation (systolic time intervals) and of relaxation rate on LV end-diastolic pressure as a potential cause of HFprEF.
26. Ashikaga H, Omens JH, Covell JW. Time-dependent remodeling of transmural architecture underlying abnormal ventricular geometry in chronic volume overload heart failure. Am J Physiol Heart Circ Physiol 2004; 287:H1994-H2002.
27. Cazorla O, Szilagyi S, Le Guennec JY, et al. Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction. FASEB J. 2005; 19:88-90. Epub 2004 Oct 21.
28. Leite-Moreira AF, Correia-Pinto J. Load as an acute determinant of end-diastolic pressure-volume relation. Am J Physiol Heart Circ Physiol 2001; 280:H51-H59.
29. He KL, Dickstein M, Sabbah HN, et al. Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res 2004; 64:72-83.
30. Maurer MS, Spevack D, Burkhoff D, Kronzon I. Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? J Am Coll Cardiol 2004; 44:1543-1549.
31. Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003; 107:656-658.
32. Solomon SB, Nikolic SD, Frater RW, Yellin EL. Contraction-relaxation coupling: determination of the onset of diastole. Am J Physiol 1999; 277:H23-H27.
33. Yano M, Kohno M, Kobayashi S, et al. Influence of timing and magnitude of arterial wave reflection on left ventricular relaxation. Am J Physiol Heart Circ Physiol 2001; 280:H1846-H1852.
34. Kohno F, Kumada T, Kambayashi M, et al. Change in aortic end-systolic pressure by alterations in loading sequence and its relation to left ventricular isovolumic relaxation. Circulation 1996; 93:2080-2087.
35. Yip G, Wang M, Zhang Y, et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002; 87:121-125.
36. Petrie MC, Caruana L, Berry C, McMurray JJ. 'Diastolic heart failure' or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002; 87:29-31.
37. Nikitin NP, Witte KK, Clark AL, Cleland JG. Color tissue Doppler-derived longaxis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol 2002; 90:1174-1177.
38. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. 'Pure' diastolic dysfunction is associated with long-axis systolic dysfunction: implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005; 7:820-828. Excellent study demonstrating that LV radial compensation for long-axis LV systolic dysfunction may 'preserve' hemodynamic pump performance, hence preserve LVEF, in patients with HFprEF.
39. ••].
40. Yu CM, Lin H, Yang H, et al. Progression of systolic abnormalities in patients with 'isolated' diastolic heart failure and diastolic dysfunction. Circulation 2002; 105:1195-1201.
41. Bruch C, Gradaus R, Gunia S, et al. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiogr 2003; 16:1031-1036.
42. Nagueh SF, McFalls J, Meyer D, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003; 108:395-398.
43. Soma J, Dahl K, Wideroe TE. Tissue Doppler imaging of the left ventricle in healthy elderly females does not support the concept of 'isolated' diastolic dysfunction. Bood Press 2005; 14:93-8.
44. Brucks S, Little WC, Chao T, et al. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 2005; 95:603-606.
45. Oh JK, Hatle L, Tajik AJ, Little WC. Dastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol. 2006; 47:500-6. Epub 2006 Jan 18.
46. Clements IP. Combined systolic and diastolic dysfunction in the presence of preserved left ventricular ejection fraction. Eur J Heart Fail 2005; 7:490-497.
47. Rosen BD, Edvardsen T, Lai S, et al. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation 2005; 112:984-991.
48. Fonseca CG, Oxenham HC, Cowan BR, et al. Aging alters patterns of regional nonuniformity in LV strain relaxation: a 3-D MR tissue tagging study. Am J Physiol Heart Circ Physiol 2003; 285:H621-H630.
49. Rosen BD, Gerber BL, Edvardsen T, et al. Late systolic onset of regional LV relaxation demonstrated in three-dimensional space by MRI tissue tagging. Am J Physiol Heart Circ Physiol 2004; 287:H1740-H1746.
50. Oh JK, Tajik J. The return of cardiac time intervals: the phoenix is rising. J Am Coll Cardiol 2003; 42:1471-1474.
51. Rivas-Gotz C, Khoury DS, Manolios M, et al. Time interval between onset of mitral inflow and onset of early diastolic velocity by tissue Doppler: a novel index of left ventricular relaxation - experimental studies and clinical application. J Am Coll Cardiol 2003; 42:1463-1470.
52. O'Rourke MF. Defining diastolic heart failure. Circulation 2001; 103:E82.
53. Lim TK, Ashrafian H, Dwivedi G, et al. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure. Eur J Heart Fail. 2006; 8:38-45. Epub 2005 Aug 22.
54. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004; 109:3176-3181.
55. Hogg K, McMurray J. Neurohumoral pathways in heart failure with preserved systolic function. Prog Cardiovasc Dis 2005; 47:357-366.
56. Dahlstrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004; 6:281-287.
57. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105:595-601.
58. Dokainish H, Zoghbi WA, Lakkis NM, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005; 45:1223-1226.
59. Arques S, Roux E, Sbragia P, et al. B-type natriuretic peptide and tissue Doppler study findings in elderly patients hospitalized for acute diastolic heart failure. Am J Cardiol 2005; 96:104-107.
60. ••].
61. Brucks S, Little WC, Chao T, et al. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 2005; 95:603-606.
62. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 2004; 148:895-902.
63. Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 2006; 113:296-304.
64. Smith GL, Masoudi FA, Vaccarino V, et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003; 41:1510-1518.
65. Ekman I, Cleland JG, Andersson B, Swedberg K. Exploring symptoms in chronic heart failure. Eur J Heart Fail 2005; 7:699-703.
66. Maurer MS, King DL, El-Khoury Rumbarger L, et al. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 2005; 11:177-187. Study emphasizing the heterogeneity of different pathophysiological phenotypes in patients with HFprEF.
67. Yotti R, Bermejo J, Antoranz JC, et al. A noninvasive method for assessing impaired diastolic suction in patients with dilated cardiomyopathy. Circulation 2005; 112:2921-2929. Study suggesting that in chronic heart failure patients with dilated cardiomyopathy, ventricular dilatation itself impairs LV filling by enhancing convective deceleration, explaining why systolic and diastolic abnormalities are intimately linked in these patients.
68. •] and placing the contribution of convective deceleration in a broad physiological context.
69. Cohen-Solal A. Diastolic heart failure: myth or reality? Eur J Heart Fail 2002; 4:395-400.
70. Sanderson JE. Diastolic heart failure: fact or fiction? Heart 2003; 89:1281-1282.
71. Sanderson JE. Diastolic dysfunction and Doppler echocardiography. J Am Coll Cardiol 2005; 45:2095.
72. Klapholz M, Maurer M, Lowe AM, et al., New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004; 43:1432-1438.
73. Yusuf S, Pfeffer MA, Swedberg K, et al., CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362:777-781.
74. The Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
75. Flather MD, Shibata MC, Coats AJ, et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225.
76. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43:1439-1444.
77. Solomon SD, St John Sutton M, Lamas GA, et al., Survival And Ventricular Enlargement (SAVE) Investigators. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation 2002; 106:1251-1255.
78. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
79. Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002; 8:216-224.
80. Poole-Wilson PA, Uretsky BF, Thygesen K, et al., Atlas Study Group. Assessment of treatment with lisinopril and survival: mode of death in heart failure - findings from the ATLAS trial. Heart 2003; 89:42-48.
81. Weinberg EO, Mirotsou M, Gannon J, et al. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 2003; 12:113-127.
82. Nordmeyer J, Eder S, Mahmoodzadeh S, et al. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 2004; 110:3270-3275.
83. Haghighi K, Schmidt AG, Hoit BD, et al. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 2001; 276:24145-24152.
84. Dash R, Schmidt AG, Pathak A, et al. Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. Cardiovasc Res 2003; 57:704-714.
85. Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest 2003; 112:302-307.
86. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004; 109:972-977.
87. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24:320-328.
88. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997; 80:736-740.
89. Perhonen MA, Zuckerman JH, Levine BD. Deterioration of left ventricular chamber performance after bed rest: 'cardiovascular deconditioning' or hypovolemia? Circulation 2001; 103:1851-1857.
90. Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110:1799-1805.
91. Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003; 57:766-774.
92. De Acetis M, Notte A, Accornero F, et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res 2005; 96:1087-1094. Erratum in: Circ Res 2005; 97:e5. Melusin (= integrin-binding protein) mimics physiological (exercise) hypertrophy by inducing itself hypertrophy while protecting, at the same time, the ventricle from dilatation; its potential role in patients with HFprEF should be further explored.
93. Yelamarty RV, Moore RL, Yu FT, et al. Relaxation abnormalities in single cardiac myocytes from renovascular hypertensive rats. Am J Physiol 1992; 262:C980-C990.
94. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42:328-335.